Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Repolar Pharmaceuticals
Espoo, Uusimaa, Finlandrepolar.com ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Other
01
Overview
Repolar Pharmaceuticals has developed and commercialized resin-based topical products for wound care, nail fungus, acne, scalp/hair health in humans, as well as skin/mucosal care in animals. Their lead products include Abilar® 10% Resin Salve for wounds and Abicin® 30% Resin Lacquer for nail fungus. Efficacy is supported by clinical research; all products are based on Norway spruce resin collected sustainably from Lapland. The company’s quality management system is ISO 13485 certified.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small molecule (resin-derived compounds)Topical medicationNatural product-based therapy
- Industry
- Therapeutic Medical Devices
02
Partnerships
Evolver Fund II investment partnership to accelerate internationalization/growth.No major pharma/biotech partnerships disclosed.
Beyond the preview
Go deeper on Repolar Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Repolar Pharmaceuticals.